Main Session
Sep 28
SS 23 - Emerging Pathways and Targeted Therapies

220 - CRISPR Screening Identifies PCCB as a Mitochondrial Driver of Radioresistance via Stabilizing Mitochondrial Homeostasis

03:50pm - 04:00pm ET

Presenter(s)

Lingyi Kong, MD Headshot
Lingyi Kong, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei